Literature DB >> 1652563

Trypanosoma cruzi but not Trypanosoma brucei fails to induce a chemiluminescent signal in a macrophage hybridoma cell line.

B Vray1, P De Baetselier, A Ouaissi, Y Carlier.   

Abstract

Macrophage-Trypanosoma cruzi interactions were studied by using a newly generated macrophage hybridoma cell line (2C11-12) that was selected for its capacity to produce high levels of reactive oxygen intermediates. This cell line was found to be a suitable host cell for T. cruzi, and intracellular parasitic development could be inhibited by activation with gamma interferon. When exposed to opsonized Trypanosoma brucei, Micrococcus lysodeikticus, or Legionella pneumophila, the activated macrophage cell line produces a high chemiluminescent signal, indicating the release of reactive oxygen intermediates. Alternatively, when opsonized T. cruzi was added to these activated macrophages, this parasite failed to stimulate a chemiluminescent response, suggesting an impairment in the triggering of the respiratory burst.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652563      PMCID: PMC258170          DOI: 10.1128/iai.59.9.3303-3308.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Infectivity of amastigotes of Trypanosoma cruzi.

Authors:  T U de Carvalho; W de Souza
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1986 Jul-Aug       Impact factor: 1.846

2.  Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.

Authors:  A H Ding; C F Nathan
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

3.  The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line.

Authors:  P Scott; S James; A Sher
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

Review 4.  The biology of Trypanosoma cruzi-macrophage interaction.

Authors:  T C de Araújo-Jorge
Journal:  Mem Inst Oswaldo Cruz       Date:  1989 Oct-Dec       Impact factor: 2.743

5.  Trypanosoma cruzi: modulation of parasite-cell interaction by plasma fibronectin.

Authors:  M A Ouaissi; J Cornette; A Capron
Journal:  Eur J Immunol       Date:  1985-11       Impact factor: 5.532

6.  Rat macrophage treatment with lipopolysaccharide leads to a reduction in respiratory burst product secretion and a decrease in NADPH oxidase affinity.

Authors:  W J Johnson; C P Sung
Journal:  Cell Immunol       Date:  1987-08       Impact factor: 4.868

7.  Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages.

Authors:  J R Catterall; C M Black; J P Leventhal; N W Rizk; J S Wachtel; J S Remington
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

8.  Effect of protective and non-protective antibodies in the phagocytosis rate of Trypanosoma cruzi blood forms by mouse peritoneal macrophages.

Authors:  E Lages-Silva; L E Ramirez; A U Krettli; Z Brener
Journal:  Parasite Immunol       Date:  1987-01       Impact factor: 2.280

9.  Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function.

Authors:  M A Ouaissi; D Afchain; A Capron; J A Grimaud
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

Review 10.  Interferon-gamma, the activated macrophage, and host defense against microbial challenge.

Authors:  H W Murray
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

View more
  9 in total

1.  Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes.

Authors:  E O Olivares Fontt; P De Baetselier; C Heirman; K Thielemans; R Lucas; B Vray
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection.

Authors:  Mustapha Chamekh; Vincent Vercruysse; Mohammed Habib; Maxime Lorent; Michel Goldman; Abdelmounaïm Allaoui; Bernard Vray
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.

Authors:  D Chaussabel; F Jacobs; J de Jonge; M de Veerman; Y Carlier; K Thielemans; M Goldman; B Vray
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice.

Authors:  E Olivares Fontt; C Heirman; K Thielemans; B Vray
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  The effect of aqueous extracts of Hibiscus sabdariffa (Sorrel) calyces on heamatological profile and organ pathological changes in Trypanasoma congolense - infected rats.

Authors:  Ismaila A Umar; Nelson G Maryoms; Emmanuel Daikwo; Abubakar Gidado; Lawan B Buratai; Ikechukwu O Igbokwe; Mohammed A Ibrahim
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-07-03

6.  Murine macrophages use oxygen- and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes.

Authors:  A P Gobert; S Semballa; S Daulouede; S Lesthelle; M Taxile; B Veyret; P Vincendeau
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Impaired protein catabolism in Trypanosoma cruzi-infected macrophages: possible involvement in antigen presentation.

Authors:  N Plasman; J G Guillet; B Vray
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

8.  Interferon-gamma-activated immature macrophages exhibit a high Trypanosoma cruzi infection rate associated with a low production of both nitric oxide and tumor necrosis factor-alpha.

Authors:  N Plasman; G Metz; B Vray
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

9.  Fertility, gestation outcome and parasite congenital transmissibility in mice infected with TcI, TcII and TcVI genotypes of Trypanosoma cruzi.

Authors:  Sabrina Cencig; Nicolas Coltel; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.